Decibel Therapeutics Inc (DBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,780 | 36,455 | 51,413 | 37,690 | 52,239 |
| Marketable Securities | 123,658 | 112,292 | 92,477 | 118,077 | 129,839 |
| Receivables | 10,000 | 11,402 | 3,142 | 1,719 | 4,237 |
| TOTAL | $151,243 | $164,191 | $149,867 | $161,301 | $190,734 |
| Non-Current Assets | |||||
| PPE Net | 5,110 | 5,611 | 5,798 | 5,633 | 5,975 |
| Investments And Advances | 5,003 | 13,547 | 28,494 | 28,833 | 8,999 |
| Other Non-Current Assets | 12,429 | 1,128 | 1,128 | 1,128 | 1,378 |
| TOTAL | $22,542 | $20,286 | $35,420 | $35,594 | $16,352 |
| Total Assets | $173,785 | $184,477 | $185,287 | $196,895 | $207,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,211 | 4,012 | 1,814 | 2,141 | 1,000 |
| Accrued Expenses | 5,328 | 7,712 | 7,552 | 5,573 | 3,835 |
| TOTAL | $18,109 | $20,538 | $16,499 | $16,637 | $15,191 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,888 | 8,814 | 7,133 | 8,923 | 10,356 |
| Other Non-Current Liabilities | 13,896 | 1,611 | 1,785 | 350 | 376 |
| TOTAL | $27,556 | $22,250 | $14,633 | $10,847 | $11,629 |
| Total Liabilities | $45,665 | $42,788 | $31,132 | $27,484 | $26,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,965 | 24,956 | 24,923 | 24,898 | 24,902 |
| Common Shares | 25 | 25 | 25 | 25 | 25 |
| Retained earnings | -228,528 | -214,512 | -201,609 | -185,210 | -173,559 |
| Other shareholders' equity | -527 | -132 | 8 | 5 | -21 |
| TOTAL | $128,120 | $141,689 | $154,155 | $169,411 | $180,266 |
| Total Liabilities And Equity | $173,785 | $184,477 | $185,287 | $196,895 | $207,086 |